Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microcephalin 1 (MCPH1) is a multifunctional, evolutionarily conserved protein encoded by the MCPH1 gene on chromosome 8p23.1. The canonical full-length protein contains 835 amino acids and includes three BRCT (BRCA1 C-Terminal) domains, key for protein-protein interactions in DNA repair, cell cycle checkpoints, and chromatin remodeling. MCPH1 plays a central role in regulating chromosome condensation during the G2/M phase transition, facilitating DNA repair via interaction with multiple DNA repair proteins, and is involved in the control of centrosome and spindle function during mitosis. Loss-of-function mutations in MCPH1 cause autosomal recessive primary microcephaly, characterized by severely reduced brain size and intellectual disability. Additionally, MCPH1 acts as a tumor suppressor and is implicated in the maintenance of genome integrity. No drugs are known to directly interact with MCPH1, and it is not currently considered a therapeutic target.
Not applicable; no direct drug mechanisms established for this protein
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microcephalin 1 (MCPH1).